Xenetic Biosciences, Inc.
XBIO
$2.43
$0.02150.89%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -31.36% | -30.04% | -31.95% | -34.77% | -31.41% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 279.58% | -50.07% | 54.03% | -32.21% | -81.33% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -94.40% | -96.00% | -86.34% | -42.75% | -- |
| Total Current Assets | -31.29% | -37.57% | -33.46% | -34.93% | -29.78% |
|
|
|||||
| Total Current Assets | -31.29% | -37.57% | -33.46% | -34.93% | -29.78% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -69.18% | 44.58% | 44.58% | 20.61% | -4.55% |
| Total Assets | -34.92% | -32.73% | -29.15% | -31.51% | -27.96% |
|
|
|||||
| Total Accounts Payable | 17.77% | -45.76% | 28.15% | -18.79% | -16.21% |
| Total Accrued Expenses | 7.35% | 23.58% | 100.62% | -15.27% | -27.62% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 10.46% | -5.53% | 82.21% | -16.34% | -24.56% |
|
|
|||||
| Total Current Liabilities | 10.46% | -5.53% | 82.21% | -16.34% | -24.56% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 10.46% | -5.53% | 82.21% | -16.34% | -24.56% |
|
|
|||||
| Common Stock & APIC | 0.08% | 0.11% | 0.13% | 0.14% | 0.14% |
| Retained Earnings | -2.05% | -2.12% | -2.46% | -2.35% | -2.19% |
| Treasury Stock & Other | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Common Equity | -38.68% | -35.40% | -37.32% | -32.52% | -28.22% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 0.00% | -35.71% | -35.71% | -35.71% | -35.71% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 0.00% | -35.71% | -35.71% | -35.71% | -35.71% |
|
|
|||||
| Total Common Equity | -38.68% | -35.40% | -37.32% | -32.52% | -28.22% |
| Total Preferred Equity | 0.00% | -35.71% | -35.71% | -35.71% | -35.71% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -38.67% | -35.40% | -37.31% | -32.52% | -28.22% |
|
|
|||||